Ou YC - Search Results

1

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder-Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes.

Ou YC, Kao YL, Ho YH, Wu KY, Kuo HC. Ou YC, et al. Toxins (Basel). 2023 Jan 19;15(2):95. doi: 10.3390/toxins15020095. Toxins (Basel). 2023. PMID: 36828410 Free PMC article.

2

The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.

Kao YL, Huang KH, Kuo HC, Ou YC. Kao YL, et al. Among authors: ou yc. Toxins (Basel). 2019 Dec 13;11(12):728. doi: 10.3390/toxins11120728. Toxins (Basel). 2019. PMID: 31847090 Free PMC article. Review.

3

Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors.

Ou YC, Huang KH, Jan HC, Kuo HC, Kao YL, Tsai KJ. Ou YC, et al. Toxins (Basel). 2021 Jun 2;13(6):398. doi: 10.3390/toxins13060398. Toxins (Basel). 2021. PMID: 34199493 Free PMC article.

4

Tumor Necrosis with Adjunction of Preoperative Monocyte-to-Lymphocyte Ratio as a New Risk Stratification Marker Can Independently Predict Poor Outcomes in Upper Tract Urothelial Carcinoma.

Lin KC, Jan HC, Hu CY, Ou YC, Kao YL, Yang WH, Ou CH. Lin KC, et al. Among authors: ou yc, ou ch. J Clin Med. 2021 Jul 3;10(13):2983. doi: 10.3390/jcm10132983. J Clin Med. 2021. PMID: 34279467 Free PMC article.

5

Bladder Dysfunction in Older Adults: The Botulinum Toxin Option.

Kao YL, Ou YC, Kuo HC. Kao YL, et al. Among authors: ou yc. Drugs Aging. 2022 Jun;39(6):401-416. doi: 10.1007/s40266-022-00950-1. Epub 2022 Jun 13. Drugs Aging. 2022. PMID: 35696022 Review.

6

The feasibility of a multimodal exercise program for sedentary postmenopausal women with urinary incontinence: A pilot randomized controlled trial.

Li YT, Tsai YJ, Wang LY, Ou YC, Kao YL, Lin KY. Li YT, et al. Among authors: ou yc. Maturitas. 2023 Jan;167:90-98. doi: 10.1016/j.maturitas.2022.10.004. Epub 2022 Oct 27. Maturitas. 2023. PMID: 36327627 Clinical Trial.

7

Bladder Management Strategies for Urological Complications in Patients with Chronic Spinal Cord Injury.

Chen YC, Ou YC, Hu JC, Yang MH, Lin WY, Huang SW, Lin WY, Lin CC, Lin VC, Chuang YC, Kuo HC; Taiwan Continence Society Spinal Cord Injury Study Group. Chen YC, et al. Among authors: ou yc. J Clin Med. 2022 Nov 20;11(22):6850. doi: 10.3390/jcm11226850. J Clin Med. 2022. PMID: 36431327 Free PMC article. Review.

8

Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection.

Kao YL, Ou YC, Tsai KJ, Kuo HC. Kao YL, et al. Among authors: ou yc. Toxins (Basel). 2022 Dec 15;14(12):877. doi: 10.3390/toxins14120877. Toxins (Basel). 2022. PMID: 36548774 Free PMC article.

9

Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction.

Ou YC, Huang CC, Kao YL, Ho PC, Tsai KJ. Ou YC, et al. Stem Cell Rev Rep. 2023 Aug;19(6):1691-1708. doi: 10.1007/s12015-023-10547-9. Epub 2023 Apr 28. Stem Cell Rev Rep. 2023. PMID: 37115409 Review.

10

Therapeutic efficacy of 180-W GreenLight laser photoselective vaporization of the prostate for storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors.

Hsieh YC, Wang CT, Kao YL, Cheng YS, Wu KY, Ho YH, Chuang MS, Huang YC, Ou YC. Hsieh YC, et al. Among authors: ou yc. Neurourol Urodyn. 2024 Mar;43(3):646-654. doi: 10.1002/nau.25409. Epub 2024 Feb 5. Neurourol Urodyn. 2024. PMID: 38314960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters